Viewing Study NCT00649051


Ignite Creation Date: 2025-12-24 @ 11:48 PM
Ignite Modification Date: 2026-01-31 @ 3:28 PM
Study NCT ID: NCT00649051
Status: COMPLETED
Last Update Posted: 2024-04-24
First Post: 2008-03-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Fasting Study of Metolazone Tablets 2.5 mg and Zaroloxyn® Tablets 2.5 mg
Sponsor: Mylan Pharmaceuticals Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module